Actionable news
0
All posts from Actionable news
Actionable news in ATRA: ATARA BIOTHERAPEUTICS INC,

Atara Biotherapeutics Inc.

Average Recommendation: Overweight Average Target Price: 28.60
Number of Ratings: 6 Current Quarters Estimate: -0.55
FY Report Date: 12 / 2016 Current Year's Estimate: -2.36
Last Quarter's Earnings: -0.75 Median PE on CY...

More